Drug Safety

杂志介绍

Drug Safety杂志介绍

《Drug Safety》是一本以English为主的未开放获取国际优秀期刊，中文名称药物安全，本刊主要出版、报道医学-公共卫生、环境卫生与职业卫生领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为5.9，最新CiteScore 指数为8.4。

本刊近期中国学者发表的论文主要有：

• Risk of Cancer Comparing Warfarin and Direct Oral Anticoagulants: Population-Based Cohort Studies in England and Hong Kon

  Author: Wang, Zixuan; Yu, Qiuyan; Matthewman, Julian; Tazare, John; Majano, Sara Benitez; Brown, Jeremy; Cheung, Ka Shing; Chui, Celine S. L.; Chan, Esther W. Y.; Bhaskaran, Krishnan; Wong, Ian C. K.; Douglas, Ian J.; Wong, Angel Y. S

• Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION Projec

  Author: Beau, Anna-Belle; Paoletti, Olga; Benevent, Justine; Beslay, Marie; Moisset, Xavier; Ballardini, Elisa; Barrachina-Bonet, Laia; Cavero-Carbonell, Clara; Coldea, Alex; Garcia-Villodre, Laura; Geldhof, Anja; Gini, Rosa; Gissler, Mika; Jordan, Sue; Leinonen, Maarit K.; Manfrini, Marco; Martikainen, Visa; Mitter, Vera R.; Morris, Joan K.; Neville, Amanda J.; Nordeng, Hedvig; Puccini, Aurora; Mo, Jingping; Damase-Michel, Christine

• IQ DILI Consensus Opinion: Best Practices for Rechallenge Following Suspected Drug-Induced Liver Injury in Clinical Trial

  Author: Steplewski, Klaudia; Walker, Lucy; Coffee, Nefeteria; Fallon, Maura; Yonemochi, Rie; Alpers, David; Rockey, Don; Lewis, James; Cohen, Eric; Caminis, John; Hey-Hadavi, Judith; Andrade, Raul Jesus; Palmer, Melissa

• Clinical Relatedness and Stability of vigiVec Semantic Vector Representations of Adverse Events and Drugs in Pharmacovigilanc

  Author: Erlanson, Nils; China, Joana Felix; Taavola, Henric; Noren, G. Niklas

英文介绍

Drug Safety杂志英文介绍

Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes:

Overviews of contentious or emerging issues.

Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes.

In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area.

Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics.

Editorials and commentaries on topical issues.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.